Nov 4 2010
Accuray is presenting 40 selected abstracts, revealing the utilization of CyberKnife Robotic Radiosurgery System, in booth #1313 at the 52nd Annual Meeting of the American Society for Radiation Oncology (ASTRO) organized in San Diego, between October 31 and November 4. These abstracts were demonstrated as posters and lectures at the meeting.
Lectures based on CyberKnife radiosurgery highlight a wide range of medical symptoms like lung, intracranial, spine, renal, head and neck. Technical presentations covering breast cancer research and low-cost diagnosis of pancreatic cancer will be a part of the meeting. In addition to this, three abstracts revealing the current Accuray-funded clinical research including the fatal lung cancer research and two prostate cancer studies will be offered at ASTRO.
At the conference, lectures on various topics including applications of CyberKnife Radiosurgery and advancements in respiratory tracking to the upcoming SRS and options with Robotic IMRT have been organized by Accuray.
The recent abilities of Accuray’s CyberKnife VSI System that was released at previous year’s ASTRO conference, as well as the latest technology, named Lung Optimized Treatment, awaiting 510(k) approval from the U.S. Food and Drug Administration (FDA) are also displayed. The Lung Optimized Treatment is developed to widen the efficiency of the CyberKnife robot in adopting a non-invasive approach for tracing the tumor movement. This technology can probably provide the fiducial-free treatment options for lung cancer victims.
According to Euan S. Thomson, President and CEO of Accuray, CyberKnife has accomplished major progress as revealed by the installation of the 206th CyberKnife System, treatment of the 100,000th patient and increased utilization of this technology for treating extracranial tumors like lung and prostate. He added that the presentations made at ASTRO reveal the enhanced utilization of CyberKnife robotic radiosurgery in treating cancer. Also all the ASTRO participants can visit the close by CyberKnife centers located in San Diego on November 1 and November 2.
Source: http://www.accuray.com